Novo Nordisk’s DEVOTE study reveals interesting findings.
Erin Bastick, PharmD, RPh
FDA approves new diagnostic test for non-small cell lung cancer.
FDA approved the use of a new fluoroquinolone antibiotic to treat ABSSSI.
Potential public health consquences prompts FDA to request removal of opioid pain medication.
Adamis’ epinephrine injection promises to be a lower-cost alterative to EpiPen.
The first generic Truvada for treating and preventing HIV will be available, but when?
FDA approves Isentress at a higher dose for HIV-1 infected patients.
A new trial for AstraZeneca’s benralizumab shows promising results for severe asthma patients.
FDA has approved the first generic versions of Strattera (atomoxetine) for the treatment of attention deficit/hyperactivity disorder.
AstraZeneca voluntarily recalls professional samples of its antiplatelet agent. Here's what to do.